过导管大动脉替换后5年内早期生物假体损坏
Maroun Chedid1, Andrew Adamek1, Seth Bergstedt1
1Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
The Canadian journal of cardiology
|September 24, 2025
概括
经过过导管大动脉置换 (TAVR) 后的早期生物假体恶化发生在14.3%的患者中. 低衰减叶片加厚 (HALT) 与BVD有关,而抗凝药似乎可以防止BVD的发展.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物材料科学 生物材料科学
背景情况:
- 过导管大动脉置换 (TAVR) 后的早期生物假体恶化 (BVD) 是一个重要的临床问题,在5年内影响高达10%的患者.
- 了解早期BVD的患病率,风险因素和临床影响对于改善TAVR结果至关重要.
研究的目的:
- 在TAVR后5年内评估早期BVD的患病率和危险因素.
- 评估早期BVD的临床影响,包括其与低衰减叶片加厚 (HALT) 和抗凝状态的关联.
主要方法:
- 对306名接受TAVR的患者进行了回顾性队列研究.
- 早期BVD是由门学术研究联盟-3标准定义的.
- 分析HALT,抗凝血和早期BVD之间的关联;临床结果的Kaplan-Meier曲线.
主要成果:
- 在14.3%的患者中观察到早期BVD.
- 低衰减的叶片加厚 (HALT) 与早期BVD (30%与5%相比) 有着强烈的关联.
- 在TAVR的抗凝血与早期BVD (4.3%对20.6%) 和HALT.的较低率有关.
结论:
- 在这个队列中,早期BVD的患病率高于之前报告的.
- HALT是早期BVD的一个显著预测因素.
- 抗凝药可能提供对BVD的保护作用,这需要进一步调查.
相关概念视频
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
412
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
412
Aortic Regurgitation I: Introduction
485
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
485
Aneurysm III: Interprofessional Care
255
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
255
Aortic Regurgitation III: Medical Management
397
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
397
Mitral Valve Prolapse I: Introduction
393
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
393


